- Report
- January 2024
- 95 Pages
From €3096EUR$3,450USD£2,664GBP
- Report
- January 2024
- 94 Pages
Middle East, Africa
From €3096EUR$3,450USD£2,664GBP
- Report
- January 2024
- 155 Pages
Global
From €3993EUR$4,450USD£3,437GBP
- Report
- January 2024
- 199 Pages
Global
From €3993EUR$4,450USD£3,437GBP
- Report
- November 2023
- 209 Pages
Global
From €3993EUR$4,450USD£3,437GBP
- Report
- September 2023
- 138 Pages
Global
From €3993EUR$4,450USD£3,437GBP
- Report
- August 2023
- 205 Pages
Europe
From €3096EUR$3,450USD£2,664GBP
- Report
- July 2023
- 220 Pages
From €3096EUR$3,450USD£2,664GBP
- Report
- July 2023
- 224 Pages
North America
From €3096EUR$3,450USD£2,664GBP
- Report
- July 2023
- 230 Pages
Africa, Middle East
From €3096EUR$3,450USD£2,664GBP
- Report
- July 2023
- 253 Pages
Europe
From €3096EUR$3,450USD£2,664GBP
- Report
- June 2023
- 250 Pages
Asia Pacific
From €3096EUR$3,450USD£2,664GBP
- Report
- May 2023
- 156 Pages
Global
From €3993EUR$4,450USD£3,437GBP
- Report
- March 2023
- 346 Pages
Global
From €3993EUR$4,450USD£3,437GBP
- Report
- February 2023
- 217 Pages
Global
From €3993EUR$4,450USD£3,437GBP
- Report
- January 2023
- 156 Pages
Europe
From €3096EUR$3,450USD£2,664GBP
- Report
- January 2023
- 135 Pages
Middle East, Africa
From €3096EUR$3,450USD£2,664GBP
- Report
- January 2023
- 132 Pages
From €3096EUR$3,450USD£2,664GBP
- Report
- January 2023
- 127 Pages
North America
From €3096EUR$3,450USD£2,664GBP
- Report
- January 2023
- 166 Pages
Asia Pacific
From €3096EUR$3,450USD£2,664GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more